ArticleDisease models & mechanisms2018

Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.

Gigin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.